Printer Friendly

Mexico Grants Quick-Med Technologies, Inc. Notice of Allowance for Its Nimbus(R) Technology.

GAINESVILLE, Fla. -- Quick-Med Technologies, Inc. (OTCBB: QMDT) ("Quick-Med Technologies" or the "Company") announced today a patent was allowed by the Mexican Patent Office, Instituto Mexicano de la Propiedad Industrial, to protect the Company's intellectual property involving its NIMBUS[R] technology.

The patent titled "Intrinsically Bactericidal Absorbent Dressing and Method of Fabrication," has claims that cover the composition of permanently bonded antimicrobial absorbent materials and the process for producing them. Similar patents have now been allowed in the U.S., China, Australia, Russia, and Indonesia.

"We are pleased that the patents underlying our intellectual property continue to issue globally, supporting our efforts to expand into promising international markets," said David S. Lerner, President of Quick-Med Technologies. "This allowance is particularly significant because it affords protection to our IP in a venue where the opportunity to produce medical devices can be accomplished at a very low cost," added Mr. Lerner.

Additional information regarding Quick-Med Technologies' Intellectual portfolio can be found in the Company's Form 10-KSB filed with the Securities and Exchange Commission.

About NIMBUS[TM]

The Company's patented technology, NIMBUS[R], employs a family of advanced antimicrobial polymers that destroy bacteria at the cellular level, thereby eliminating the risk of developing drug resistance. Unlike any other microbicide on the market today, the NIMBUS technology works by creating a permanent bond with a multitude of substrates (without leaching) and is less than 10% the cost of silver-based antimicrobials. NIMBUS is highly effective, including against methicillin-resistant Staphylococcus aureus ("MRSA") and vancomycin-resistant Enterococcus ("VRE"), two of the most significant antibiotic-resistant organisms responsible for hospital infections.

About Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc. is a life sciences company focused on developing broad-based technologies within the healthcare and consumer markets. The Company's two core products under development are the (1) NIMBUS[R], a technology employing advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer products; and (2) MultiStat[TM] family of advanced patented methods and compounds, shown to be effective in key skin care therapy applications for cosmetic, military, and medical markets. Quick-Med Technologies, Inc. is listed under the symbol "QMDT" on the OTC Bulletin Board. Visit Quick-Med Technologies at www.quickmedtech.com

(c) 2007 Quick-Med Technologies, Inc. All rights reserved. NIMBUS[R] and MultiStat[TM] are trademarks of Quick-Med Technologies, Inc. All other trademarks are the property of their respective owners.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov. The notice of allowance from the Mexican Patent Office for the Company's NIMBUS[R] technology entitled "Intrinsically Bactericidal Absorbent Dressing and Method of Fabrication," should not be construed by any means as an indication of the present or future value of the Company or its common stock. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, the Company does not undertake, and it specifically disclaims any obligation, to update any forward looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 2, 2007
Words:628
Previous Article:COMSYS IT Partners, Inc. Announces Preliminary Second Quarter Results.
Next Article:GlobalOptions Announces Filing of Registration Statement.


Related Articles
Private sector technology experience applied to a school district.
Integrating passives: to save real estate and enhance reliability, even the DoD is embedding parts.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters